rs4674

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000709.4(BCKDHA):​c.1221A>G​(p.Leu407Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.612 in 1,613,672 control chromosomes in the GnomAD database, including 305,356 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. L407L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.66 ( 33918 hom., cov: 31)
Exomes 𝑓: 0.61 ( 271438 hom. )

Consequence

BCKDHA
NM_000709.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.759

Publications

44 publications found
Variant links:
Genes affected
BCKDHA (HGNC:986): (branched chain keto acid dehydrogenase E1 subunit alpha) The branched-chain alpha-keto acid (BCAA) dehydrogenase (BCKD) complex is an innter mitochondrial enzyme complex that catalyzes the second major step in the catabolism of the branched-chain amino acids leucine, isoleucine, and valine. The BCKD complex consists of three catalytic components: a heterotetrameric (alpha2-beta2) branched-chain alpha-keto acid decarboxylase (E1), a dihydrolipoyl transacylase (E2), and a dihydrolipoamide dehydrogenase (E3). This gene encodes the alpha subunit of the decarboxylase (E1) component. Mutations in this gene result in maple syrup urine disease, type IA. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]
BCKDHA Gene-Disease associations (from GenCC):
  • maple syrup urine disease
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • maple syrup urine disease type 1A
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P, Myriad Women’s Health, ClinGen
  • classic maple syrup urine disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • intermediate maple syrup urine disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • intermittent maple syrup urine disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • thiamine-responsive maple syrup urine disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant 19-41424491-A-G is Benign according to our data. Variant chr19-41424491-A-G is described in ClinVar as Benign. ClinVar VariationId is 93343.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.759 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.814 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000709.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BCKDHA
NM_000709.4
MANE Select
c.1221A>Gp.Leu407Leu
synonymous
Exon 9 of 9NP_000700.1
BCKDHA
NM_001164783.2
c.1218A>Gp.Leu406Leu
synonymous
Exon 9 of 9NP_001158255.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BCKDHA
ENST00000269980.7
TSL:1 MANE Select
c.1221A>Gp.Leu407Leu
synonymous
Exon 9 of 9ENSP00000269980.2
ENSG00000255730
ENST00000540732.3
TSL:2
c.1323A>Gp.Leu441Leu
synonymous
Exon 10 of 10ENSP00000443246.1
BCKDHA
ENST00000919033.1
c.1449A>Gp.Leu483Leu
synonymous
Exon 10 of 10ENSP00000589092.1

Frequencies

GnomAD3 genomes
AF:
0.658
AC:
99862
AN:
151750
Hom.:
33876
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.822
Gnomad AMI
AF:
0.772
Gnomad AMR
AF:
0.561
Gnomad ASJ
AF:
0.627
Gnomad EAS
AF:
0.437
Gnomad SAS
AF:
0.589
Gnomad FIN
AF:
0.663
Gnomad MID
AF:
0.639
Gnomad NFE
AF:
0.602
Gnomad OTH
AF:
0.639
GnomAD2 exomes
AF:
0.592
AC:
147600
AN:
249152
AF XY:
0.592
show subpopulations
Gnomad AFR exome
AF:
0.825
Gnomad AMR exome
AF:
0.479
Gnomad ASJ exome
AF:
0.626
Gnomad EAS exome
AF:
0.431
Gnomad FIN exome
AF:
0.656
Gnomad NFE exome
AF:
0.605
Gnomad OTH exome
AF:
0.608
GnomAD4 exome
AF:
0.607
AC:
886891
AN:
1461804
Hom.:
271438
Cov.:
70
AF XY:
0.606
AC XY:
440439
AN XY:
727208
show subpopulations
African (AFR)
AF:
0.833
AC:
27873
AN:
33480
American (AMR)
AF:
0.485
AC:
21706
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.625
AC:
16340
AN:
26134
East Asian (EAS)
AF:
0.465
AC:
18449
AN:
39698
South Asian (SAS)
AF:
0.583
AC:
50314
AN:
86258
European-Finnish (FIN)
AF:
0.655
AC:
34970
AN:
53388
Middle Eastern (MID)
AF:
0.637
AC:
3673
AN:
5768
European-Non Finnish (NFE)
AF:
0.608
AC:
676435
AN:
1111970
Other (OTH)
AF:
0.615
AC:
37131
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
21261
42522
63783
85044
106305
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18298
36596
54894
73192
91490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.658
AC:
99957
AN:
151868
Hom.:
33918
Cov.:
31
AF XY:
0.655
AC XY:
48630
AN XY:
74198
show subpopulations
African (AFR)
AF:
0.822
AC:
34072
AN:
41462
American (AMR)
AF:
0.561
AC:
8563
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.627
AC:
2177
AN:
3470
East Asian (EAS)
AF:
0.438
AC:
2251
AN:
5140
South Asian (SAS)
AF:
0.588
AC:
2823
AN:
4804
European-Finnish (FIN)
AF:
0.663
AC:
6991
AN:
10552
Middle Eastern (MID)
AF:
0.636
AC:
187
AN:
294
European-Non Finnish (NFE)
AF:
0.602
AC:
40846
AN:
67860
Other (OTH)
AF:
0.639
AC:
1346
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
1705
3410
5115
6820
8525
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
788
1576
2364
3152
3940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.620
Hom.:
54849
Bravo
AF:
0.658
Asia WGS
AF:
0.538
AC:
1869
AN:
3478
EpiCase
AF:
0.598
EpiControl
AF:
0.604

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
Maple syrup urine disease (4)
-
-
4
not specified (4)
-
-
2
not provided (2)
-
-
1
Maple syrup urine disease type 1A (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.66
CADD
Benign
8.0
DANN
Benign
0.79
PhyloP100
0.76
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4674; hg19: chr19-41930396; COSMIC: COSV54195656; COSMIC: COSV54195656; API